Crinetics Pharmaceuticals (CRNX) Other Non-Current Assets (2017 - 2026)

Crinetics Pharmaceuticals' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $800000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 38.46% year-over-year to $800000.0; the TTM figure through Mar 2026 stood at $800000.0 (down 38.46% YoY), while the FY2025 annual figure was $22.3 million, up 2690.88% from the prior year.
• Other Non-Current Assets was $800000.0 for Q1 2026 at Crinetics Pharmaceuticals, down from $22.3 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $22.3 million in Q4 2025 to a low of $500000.0 in Q1 2022.
• Historically, Other Non-Current Assets has averaged $2.4 million across 5 years, with a median of $1.3 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets slumped 38.46% in 2024, then soared 2690.88% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $1.3 million in 2022, then declined by 0.08% to $1.3 million in 2023, then tumbled by 38.46% to $800000.0 in 2024, then jumped by 2690.88% to $22.3 million in 2025, then plunged by 96.42% to $800000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $800000.0 (Q1 2026), $22.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.